Research Article

Network Pharmacology and Pharmacological Mechanism of CV-3 in Atrial Fibrillation

Figure 2

The active components and potential targets of CV-3 in AF treatment. (a) Overlapped targets of CV-3 and AF presented in the Venn diagram. (b, c) Analysis of the 24 overlapped targets in a protein-protein interaction (PPI) network using STRING and Cytoscape, respectively. (d) The drug-compound-target-disease network of CV-3 in treating AF. Pink nodes represent the 5 components of CV-3, yellow nodes represent key targets of AF, and red represents CV-3.
(a)
(b)
(c)
(d)